{"name":"Sinovac Biotech Co., Ltd","slug":"sinovac-biotech-co-ltd","ticker":"","exchange":"","domain":"sinovac.com","description":"","hq":"Beijing","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":42,"colorKey":"oncology","drugs":[{"name":"DTaP-IPV-Hib","genericName":"DTaP-IPV-Hib","slug":"dtap-ipv-hib","indication":"Other","status":"marketed"},{"name":"Two doses of quadrivalent influenza vaccine","genericName":"Two doses of quadrivalent influenza vaccine","slug":"two-doses-of-quadrivalent-influenza-vaccine","indication":"Other","status":"marketed"},{"name":"wIPV-wIPV-bOPV vaccination schedule","genericName":"wIPV-wIPV-bOPV vaccination schedule","slug":"wipv-wipv-bopv-vaccination-schedule","indication":"Prevention of poliomyelitis","status":"phase_3"},{"name":"Control IPV","genericName":"Control IPV","slug":"control-ipv","indication":"Poliomyelitis prevention in infants and children","status":"phase_3"},{"name":"Control Quadrivalent influenza virus vaccine","genericName":"Control Quadrivalent influenza virus vaccine","slug":"control-quadrivalent-influenza-virus-vaccine","indication":"Prevention of influenza caused by influenza A and B viruses in adults and children","status":"phase_3"},{"name":"EV71 inactived vaccine（Human diploid cells）","genericName":"EV71 inactived vaccine（Human diploid cells）","slug":"ev71-inactived-vaccine-human-diploid-cells","indication":"Other","status":"marketed"},{"name":"IPV control vaccine","genericName":"IPV control vaccine","slug":"ipv-control-vaccine","indication":"Poliomyelitis prevention in infants and children","status":"phase_3"},{"name":"Marketed rabies vaccine","genericName":"Marketed rabies vaccine","slug":"marketed-rabies-vaccine","indication":"Rabies post-exposure prophylaxis (PEP) in individuals exposed to potentially rabid animals","status":"phase_3"},{"name":"Mumps vaccine, Live (MV)","genericName":"Mumps vaccine, Live (MV)","slug":"mumps-vaccine-live-mv","indication":"Prevention of mumps in children and adults","status":"marketed"},{"name":"Sabin Strain Inactivated Poliovirus Vaccine","genericName":"Sabin Strain Inactivated Poliovirus Vaccine","slug":"sabin-strain-inactivated-poliovirus-vaccine","indication":"Prevention of poliomyelitis","status":"phase_3"},{"name":"Three doses of control vaccine","genericName":"Three doses of control vaccine","slug":"three-doses-of-control-vaccine","indication":"Other","status":"phase_1"},{"name":"Three doses of investigational vaccine","genericName":"Three doses of investigational vaccine","slug":"three-doses-of-investigational-vaccine","indication":"Other","status":"phase_1"},{"name":"trivalent seasonal influenza vaccine","genericName":"trivalent seasonal influenza vaccine","slug":"trivalent-seasonal-influenza-vaccine","indication":"Prevention of seasonal influenza in adults and children","status":"marketed"},{"name":"wIPV-bOPV-bOPV vaccination schedule","genericName":"wIPV-bOPV-bOPV vaccination schedule","slug":"wipv-bopv-bopv-vaccination-schedule","indication":"Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","status":"phase_3"},{"name":"whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose","genericName":"whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose","slug":"whole-virion-adjuvanted-h1n1-vaccine-of-10-g-per-dose","indication":"Other","status":"marketed"},{"name":"whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose","genericName":"whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose","slug":"whole-virion-adjuvanted-h1n1-vaccine-of-5-g-per-dose","indication":"Other","status":"marketed"},{"name":"1wIPV+2sIPV","genericName":"1wIPV+2sIPV","slug":"1wipv-2sipv","indication":"Poliomyelitis prevention in infants and children","status":"marketed"},{"name":"2wIPV+1sIPV","genericName":"2wIPV+1sIPV","slug":"2wipv-1sipv","indication":"Poliomyelitis prevention (poliovirus types 1, 2, and 3)","status":"marketed"},{"name":"3sIPV","genericName":"3sIPV","slug":"3sipv","indication":"Other","status":"marketed"},{"name":"3wIPV","genericName":"3wIPV","slug":"3wipv","indication":"Other","status":"marketed"},{"name":"Active-controlled vaccine A","genericName":"Active-controlled vaccine A","slug":"active-controlled-vaccine-a","indication":"Other","status":"phase_1"},{"name":"Active-controlled vaccine B","genericName":"Active-controlled vaccine B","slug":"active-controlled-vaccine-b","indication":"Other","status":"phase_1"},{"name":"Concomitant administration of EV71vaccine with EPI vaccines","genericName":"Concomitant administration of EV71vaccine with EPI vaccines","slug":"concomitant-administration-of-ev71vaccine-with-epi-vaccines","indication":"Other","status":"marketed"},{"name":"Experimental 23-valent PPV","genericName":"Experimental 23-valent PPV","slug":"experimental-23-valent-ppv","indication":"Other","status":"marketed"},{"name":"Experimental 23-valent Pneumococcal","genericName":"Experimental 23-valent Pneumococcal","slug":"experimental-23-valent-pneumococcal","indication":"Other","status":"marketed"},{"name":"Experimental Vaccine","genericName":"Experimental Vaccine","slug":"experimental-vaccine","indication":"Other","status":"marketed"},{"name":"Healive® Lot 1","genericName":"Healive® Lot 1","slug":"healive-lot-1","indication":"Other","status":"marketed"},{"name":"Healive® Lot 2","genericName":"Healive® Lot 2","slug":"healive-lot-2","indication":"Other","status":"marketed"},{"name":"High-dose experimental vaccine","genericName":"High-dose experimental vaccine","slug":"high-dose-experimental-vaccine","indication":"Other","status":"phase_1"},{"name":"Inactivated HAV vaccine","genericName":"Inactivated HAV vaccine","slug":"inactivated-hav-vaccine","indication":"Other","status":"marketed"},{"name":"Investigational sIPV","genericName":"Investigational sIPV","slug":"investigational-sipv","indication":"Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","status":"phase_3"},{"name":"Seasonal trivalent vaccine","genericName":"Seasonal trivalent vaccine","slug":"seasonal-trivalent-vaccine","indication":"Seasonal influenza prevention in adults and children","status":"marketed"},{"name":"Single injection of EPI vaccine","genericName":"Single injection of EPI vaccine","slug":"single-injection-of-epi-vaccine","indication":"Other","status":"marketed"},{"name":"Sinovac rabies vaccine","genericName":"Sinovac rabies vaccine","slug":"sinovac-rabies-vaccine","indication":"Pre-exposure prophylaxis against rabies","status":"phase_3"},{"name":"Vaxigrip QIV","genericName":"Vaxigrip QIV","slug":"vaxigrip-qiv","indication":"Prevention of influenza disease caused by four different strains of the influenza virus","status":"phase_3"},{"name":"Verorab®","genericName":"Verorab®","slug":"verorab","indication":"Pre-exposure prophylaxis and post-exposure prophylaxis against rabies","status":"phase_3"},{"name":"sIPV vaccine /DTaP vaccine","genericName":"sIPV vaccine /DTaP vaccine","slug":"sipv-vaccine-dtap-vaccine","indication":"Prevention of poliomyelitis (poliovirus types 1, 2, and 3)","status":"marketed"},{"name":"sIPV-bOPV-bOPV vaccination schedule","genericName":"sIPV-bOPV-bOPV vaccination schedule","slug":"sipv-bopv-bopv-vaccination-schedule","indication":"Prevention of poliomyelitis and rotavirus gastroenteritis in infants and young children","status":"phase_3"},{"name":"sIPV-sIPV-bOPV vaccination schedule","genericName":"sIPV-sIPV-bOPV vaccination schedule","slug":"sipv-sipv-bopv-vaccination-schedule","indication":"Other","status":"phase_3"},{"name":"seasonal split influenza vaccine","genericName":"seasonal split influenza vaccine","slug":"seasonal-split-influenza-vaccine","indication":"Other","status":"marketed"},{"name":"single-person sIPV control vaccine","genericName":"single-person sIPV control vaccine","slug":"single-person-sipv-control-vaccine","indication":"Other","status":"phase_3"},{"name":"split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose","genericName":"split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose","slug":"split-virion-adjuvanted-h1n1-vaccine-of-7-5-g-per-dose","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":17,"colorKey":"cardiovascular","drugs":[{"name":"EV71 Inactivated Vaccine","genericName":"EV71 Inactivated Vaccine","slug":"ev71-inactivated-vaccine","indication":"Prevention of EV71 infections","status":"phase_2"},{"name":"EV71 vaccine","genericName":"EV71 vaccine","slug":"ev71-vaccine","indication":"Prevention of enterovirus 71 infection and hand, foot, and mouth disease (HFMD) in infants and young children","status":"marketed"},{"name":"Havrix+Havrix","genericName":"Havrix+Havrix","slug":"havrix-havrix","indication":"Prevention of hepatitis A infection in adults and children","status":"marketed"},{"name":"Attenuated alive HAV vaccine","genericName":"Attenuated alive HAV vaccine","slug":"attenuated-alive-hav-vaccine","indication":"Prevention of hepatitis A","status":"phase_2"},{"name":"Control 23-valent PPV","genericName":"Control 23-valent PPV","slug":"control-23-valent-ppv","indication":"Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis) in adults and children ≥2 years of age","status":"marketed"},{"name":"Control Vaccine","genericName":"Control Vaccine","slug":"control-vaccine","indication":"Prevention of COVID-19 caused by SARS-CoV-2","status":"marketed"},{"name":"EV71 Vaccine only","genericName":"EV71 Vaccine only","slug":"ev71-vaccine-only","indication":"Prevention of Enterovirus 71 infection and hand, foot, and mouth disease (HFMD) in infants and young children","status":"marketed"},{"name":"Havrix+Healive","genericName":"Havrix+Healive","slug":"havrix-healive","indication":"Prevention of hepatitis A infection","status":"marketed"},{"name":"Healive+Havrix","genericName":"Healive+Havrix","slug":"healive-havrix","indication":"Prevention of hepatitis A infection","status":"marketed"},{"name":"Healive+Healive","genericName":"Healive+Healive","slug":"healive-healive","indication":"Prevention of hepatitis A infection","status":"marketed"},{"name":"Healive® Lot 3","genericName":"Healive® Lot 3","slug":"healive-lot-3","indication":"Prevention of hepatitis A infection in children and adults","status":"marketed"},{"name":"HepA-I","genericName":"HepA-I","slug":"hepa-i","indication":"Prevention of hepatitis A infection in children and adults","status":"marketed"},{"name":"High-dosage SARS-CoV-2 vaccine","genericName":"High-dosage SARS-CoV-2 vaccine","slug":"high-dosage-sars-cov-2-vaccine","indication":"Prevention of COVID-19 caused by SARS-CoV-2","status":"marketed"},{"name":"Investigational 23-valent PPV","genericName":"Investigational 23-valent PPV","slug":"investigational-23-valent-ppv","indication":"Prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults and children","status":"marketed"},{"name":"Live attenuated HAV vaccine","genericName":"Live attenuated HAV vaccine","slug":"live-attenuated-hav-vaccine","indication":"Prevention of hepatitis A infection in susceptible individuals","status":"marketed"},{"name":"Medium-dosage SARS-CoV-2 vaccine","genericName":"Medium-dosage SARS-CoV-2 vaccine","slug":"medium-dosage-sars-cov-2-vaccine","indication":"Prevention of COVID-19 caused by SARS-CoV-2","status":"marketed"},{"name":"Pandemic influenza A/H1N1 vaccine","genericName":"Pandemic influenza A/H1N1 vaccine","slug":"pandemic-influenza-a-h1n1-vaccine","indication":"Prevention of pandemic influenza A/H1N1 infection","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"three consecutive lots of EV71 vaccine","genericName":"three consecutive lots of EV71 vaccine","slug":"three-consecutive-lots-of-ev71-vaccine","indication":"Prevention of hand, foot, and mouth disease (HFMD) caused by enterovirus 71","status":"phase_3"},{"name":"EV71 inactived vaccine（Vero cells）","genericName":"EV71 inactived vaccine（Vero cells）","slug":"ev71-inactived-vaccine-vero-cells","indication":"Prevention of hand, foot, and mouth disease (HFMD) caused by enterovirus 71","status":"marketed"}]}],"pipeline":[{"name":"DTaP-IPV-Hib","genericName":"DTaP-IPV-Hib","slug":"dtap-ipv-hib","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Two doses of quadrivalent influenza vaccine","genericName":"Two doses of quadrivalent influenza vaccine","slug":"two-doses-of-quadrivalent-influenza-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"three consecutive lots of EV71 vaccine","genericName":"three consecutive lots of EV71 vaccine","slug":"three-consecutive-lots-of-ev71-vaccine","phase":"phase_3","mechanism":"An inactivated enterovirus 71 (EV71) vaccine that stimulates the immune system to produce antibodies against EV71, preventing infection and disease.","indications":["Prevention of hand, foot, and mouth disease (HFMD) caused by enterovirus 71","Prevention of EV71-associated neurological complications in pediatric populations"],"catalyst":""},{"name":"wIPV-wIPV-bOPV vaccination schedule","genericName":"wIPV-wIPV-bOPV vaccination schedule","slug":"wipv-wipv-bopv-vaccination-schedule","phase":"phase_3","mechanism":"The wIPV-wIPV-bOPV vaccine induces immune responses against the poliovirus types 1, 2, and 3.","indications":["Prevention of poliomyelitis"],"catalyst":""},{"name":"Control IPV","genericName":"Control IPV","slug":"control-ipv","phase":"phase_3","mechanism":"Control IPV is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.","indications":["Poliomyelitis prevention in infants and children"],"catalyst":""},{"name":"Control Quadrivalent influenza virus vaccine","genericName":"Control Quadrivalent influenza virus vaccine","slug":"control-quadrivalent-influenza-virus-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against four strains of influenza virus.","indications":["Prevention of influenza caused by influenza A and B viruses in adults and children"],"catalyst":""},{"name":"EV71 Inactivated Vaccine","genericName":"EV71 Inactivated Vaccine","slug":"ev71-inactivated-vaccine","phase":"phase_2","mechanism":"EV71 Inactivated Vaccine works by exposing the body to a small, harmless piece of the EV71 virus to stimulate the immune system to produce antibodies and provide immunity against future EV71 infections.","indications":["Prevention of EV71 infections"],"catalyst":""},{"name":"EV71 inactived vaccine（Human diploid cells）","genericName":"EV71 inactived vaccine（Human diploid cells）","slug":"ev71-inactived-vaccine-human-diploid-cells","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"EV71 vaccine","genericName":"EV71 vaccine","slug":"ev71-vaccine","phase":"marketed","mechanism":"The EV71 vaccine stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71, preventing infection and disease.","indications":["Prevention of enterovirus 71 infection and hand, foot, and mouth disease (HFMD) in infants and young children"],"catalyst":""},{"name":"Havrix+Havrix","genericName":"Havrix+Havrix","slug":"havrix-havrix","phase":"marketed","mechanism":"Havrix is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","indications":["Prevention of hepatitis A infection in adults and children"],"catalyst":""},{"name":"IPV control vaccine","genericName":"IPV control vaccine","slug":"ipv-control-vaccine","phase":"phase_3","mechanism":"IPV (inactivated poliovirus vaccine) stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3, preventing poliomyelitis infection.","indications":["Poliomyelitis prevention in infants and children","Poliomyelitis prevention in adults (booster or primary series)"],"catalyst":""},{"name":"Marketed rabies vaccine","genericName":"Marketed rabies vaccine","slug":"marketed-rabies-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against the rabies virus, preventing infection after exposure.","indications":["Rabies post-exposure prophylaxis (PEP) in individuals exposed to potentially rabid animals","Rabies pre-exposure prophylaxis (PrEP) in high-risk populations (veterinarians, laboratory workers, travelers to endemic regions)"],"catalyst":""},{"name":"Mumps vaccine, Live (MV)","genericName":"Mumps vaccine, Live (MV)","slug":"mumps-vaccine-live-mv","phase":"marketed","mechanism":"A live attenuated mumps virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against mumps virus.","indications":["Prevention of mumps in children and adults"],"catalyst":""},{"name":"Sabin Strain Inactivated Poliovirus Vaccine","genericName":"Sabin Strain Inactivated Poliovirus Vaccine","slug":"sabin-strain-inactivated-poliovirus-vaccine","phase":"phase_3","mechanism":"The Sabin Strain Inactivated Poliovirus Vaccine works by exposing the body to a weakened form of the poliovirus, stimulating an immune response to provide protection against poliovirus infection.","indications":["Prevention of poliomyelitis"],"catalyst":""},{"name":"Three doses of control vaccine","genericName":"Three doses of control vaccine","slug":"three-doses-of-control-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Three doses of investigational vaccine","genericName":"Three doses of investigational vaccine","slug":"three-doses-of-investigational-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"trivalent seasonal influenza vaccine","genericName":"trivalent seasonal influenza vaccine","slug":"trivalent-seasonal-influenza-vaccine","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against three strains of seasonal influenza virus.","indications":["Prevention of seasonal influenza in adults and children"],"catalyst":""},{"name":"wIPV-bOPV-bOPV vaccination schedule","genericName":"wIPV-bOPV-bOPV vaccination schedule","slug":"wipv-bopv-bopv-vaccination-schedule","phase":"phase_3","mechanism":"This vaccine induces immunity against poliovirus types 1, 2, and 3.","indications":["Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3"],"catalyst":""},{"name":"whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose","genericName":"whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose","slug":"whole-virion-adjuvanted-h1n1-vaccine-of-10-g-per-dose","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose","genericName":"whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose","slug":"whole-virion-adjuvanted-h1n1-vaccine-of-5-g-per-dose","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"1wIPV+2sIPV","genericName":"1wIPV+2sIPV","slug":"1wipv-2sipv","phase":"marketed","mechanism":"This is an inactivated polio vaccine combining one dose of whole-virus IPV with two doses of split-virus IPV to provide immunization against poliovirus types 1, 2, and 3.","indications":["Poliomyelitis prevention in infants and children"],"catalyst":""},{"name":"2wIPV+1sIPV","genericName":"2wIPV+1sIPV","slug":"2wipv-1sipv","phase":"marketed","mechanism":"This is a combination inactivated polio vaccine regimen using two doses of whole-virus IPV followed by one dose of split-virus IPV to provide immunization against poliovirus types 1, 2, and 3.","indications":["Poliomyelitis prevention (poliovirus types 1, 2, and 3)"],"catalyst":""},{"name":"3sIPV","genericName":"3sIPV","slug":"3sipv","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"3wIPV","genericName":"3wIPV","slug":"3wipv","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Active-controlled vaccine A","genericName":"Active-controlled vaccine A","slug":"active-controlled-vaccine-a","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Active-controlled vaccine B","genericName":"Active-controlled vaccine B","slug":"active-controlled-vaccine-b","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Attenuated alive HAV vaccine","genericName":"Attenuated alive HAV vaccine","slug":"attenuated-alive-hav-vaccine","phase":"phase_2","mechanism":"Attenuated alive HAV vaccine works by exposing the body to a weakened form of the hepatitis A virus, prompting an immune response without causing the disease.","indications":["Prevention of hepatitis A"],"catalyst":""},{"name":"Concomitant administration of EV71vaccine with EPI vaccines","genericName":"Concomitant administration of EV71vaccine with EPI vaccines","slug":"concomitant-administration-of-ev71vaccine-with-epi-vaccines","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Control 23-valent PPV","genericName":"Control 23-valent PPV","slug":"control-23-valent-ppv","phase":"marketed","mechanism":"This pneumococcal polysaccharide vaccine stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae, providing protection against pneumococcal disease.","indications":["Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis) in adults and children ≥2 years of age"],"catalyst":""},{"name":"Control Vaccine","genericName":"Control Vaccine","slug":"control-vaccine","phase":"marketed","mechanism":"Control Vaccine is an inactivated whole-virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2.","indications":["Prevention of COVID-19 caused by SARS-CoV-2"],"catalyst":""},{"name":"EV71 Vaccine only","genericName":"EV71 Vaccine only","slug":"ev71-vaccine-only","phase":"marketed","mechanism":"The EV71 vaccine stimulates the immune system to produce antibodies and cellular immunity against Enterovirus 71, preventing infection and disease.","indications":["Prevention of Enterovirus 71 infection and hand, foot, and mouth disease (HFMD) in infants and young children"],"catalyst":""},{"name":"EV71 inactived vaccine（Vero cells）","genericName":"EV71 inactived vaccine（Vero cells）","slug":"ev71-inactived-vaccine-vero-cells","phase":"marketed","mechanism":"This inactivated virus vaccine stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71 (EV71) to prevent infection and disease.","indications":["Prevention of hand, foot, and mouth disease (HFMD) caused by enterovirus 71","Prevention of EV71-associated neurological complications in infants and young children"],"catalyst":""},{"name":"Experimental 23-valent PPV","genericName":"Experimental 23-valent PPV","slug":"experimental-23-valent-ppv","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Experimental 23-valent Pneumococcal","genericName":"Experimental 23-valent Pneumococcal","slug":"experimental-23-valent-pneumococcal","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Experimental Vaccine","genericName":"Experimental Vaccine","slug":"experimental-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Havrix+Healive","genericName":"Havrix+Healive","slug":"havrix-healive","phase":"marketed","mechanism":"Havrix+Healive is a combination vaccine that provides immunization against hepatitis A and hepatitis B through inactivated viral antigens.","indications":["Prevention of hepatitis A infection","Prevention of hepatitis B infection"],"catalyst":""},{"name":"Healive+Havrix","genericName":"Healive+Havrix","slug":"healive-havrix","phase":"marketed","mechanism":"Healive+Havrix is a combination vaccine that provides immunization against hepatitis A and hepatitis B through inactivated viral antigens.","indications":["Prevention of hepatitis A infection","Prevention of hepatitis B infection"],"catalyst":""},{"name":"Healive+Healive","genericName":"Healive+Healive","slug":"healive-healive","phase":"marketed","mechanism":"Healive+Healive is a hepatitis A and hepatitis B combination vaccine that stimulates the immune system to produce antibodies against both hepatitis A and B viruses.","indications":["Prevention of hepatitis A infection","Prevention of hepatitis B infection"],"catalyst":""},{"name":"Healive® Lot 1","genericName":"Healive® Lot 1","slug":"healive-lot-1","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Healive® Lot 2","genericName":"Healive® Lot 2","slug":"healive-lot-2","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Healive® Lot 3","genericName":"Healive® Lot 3","slug":"healive-lot-3","phase":"marketed","mechanism":"Healive is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","indications":["Prevention of hepatitis A infection in children and adults"],"catalyst":""},{"name":"HepA-I","genericName":"HepA-I","slug":"hepa-i","phase":"marketed","mechanism":"HepA-I is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","indications":["Prevention of hepatitis A infection in children and adults"],"catalyst":""},{"name":"High-dosage SARS-CoV-2 vaccine","genericName":"High-dosage SARS-CoV-2 vaccine","slug":"high-dosage-sars-cov-2-vaccine","phase":"marketed","mechanism":"This inactivated SARS-CoV-2 vaccine stimulates the immune system to produce antibodies and cellular immunity against the virus by presenting inactivated viral particles.","indications":["Prevention of COVID-19 caused by SARS-CoV-2"],"catalyst":""},{"name":"High-dose experimental vaccine","genericName":"High-dose experimental vaccine","slug":"high-dose-experimental-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Inactivated HAV vaccine","genericName":"Inactivated HAV vaccine","slug":"inactivated-hav-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Investigational 23-valent PPV","genericName":"Investigational 23-valent PPV","slug":"investigational-23-valent-ppv","phase":"marketed","mechanism":"A 23-valent pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.","indications":["Prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults and children"],"catalyst":""},{"name":"Investigational sIPV","genericName":"Investigational sIPV","slug":"investigational-sipv","phase":"phase_3","mechanism":"sIPV is an inactivated poliomyelitis vaccine that stimulates immune responses against poliovirus types 1, 2, and 3 to prevent poliomyelitis infection.","indications":["Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3"],"catalyst":""},{"name":"Live attenuated HAV vaccine","genericName":"Live attenuated HAV vaccine","slug":"live-attenuated-hav-vaccine","phase":"marketed","mechanism":"This vaccine contains live attenuated (weakened) hepatitis A virus that stimulates the immune system to produce antibodies and cellular immunity against hepatitis A without causing disease.","indications":["Prevention of hepatitis A infection in susceptible individuals"],"catalyst":""},{"name":"Medium-dosage SARS-CoV-2 vaccine","genericName":"Medium-dosage SARS-CoV-2 vaccine","slug":"medium-dosage-sars-cov-2-vaccine","phase":"marketed","mechanism":"This inactivated SARS-CoV-2 vaccine stimulates the immune system to produce antibodies and cellular immunity against the virus by presenting inactivated viral particles.","indications":["Prevention of COVID-19 caused by SARS-CoV-2"],"catalyst":""},{"name":"Pandemic influenza A/H1N1 vaccine","genericName":"Pandemic influenza A/H1N1 vaccine","slug":"pandemic-influenza-a-h1n1-vaccine","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against pandemic influenza A/H1N1 virus.","indications":["Prevention of pandemic influenza A/H1N1 infection"],"catalyst":""},{"name":"Seasonal trivalent vaccine","genericName":"Seasonal trivalent vaccine","slug":"seasonal-trivalent-vaccine","phase":"marketed","mechanism":"The seasonal trivalent influenza vaccine stimulates the immune system to produce antibodies against three strains of influenza virus, providing protection against seasonal flu infection.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"Single injection of EPI vaccine","genericName":"Single injection of EPI vaccine","slug":"single-injection-of-epi-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Sinovac rabies vaccine","genericName":"Sinovac rabies vaccine","slug":"sinovac-rabies-vaccine","phase":"phase_3","mechanism":"The Sinovac rabies vaccine works by stimulating the body's immune system to produce antibodies against the rabies virus.","indications":["Pre-exposure prophylaxis against rabies"],"catalyst":""},{"name":"Vaxigrip QIV","genericName":"Vaxigrip QIV","slug":"vaxigrip-qiv","phase":"phase_3","mechanism":"Vaxigrip QIV is a quadrivalent inactivated influenza vaccine that stimulates the body's immune system to produce antibodies against four different influenza viruses.","indications":["Prevention of influenza disease caused by four different strains of the influenza virus"],"catalyst":""},{"name":"Verorab®","genericName":"Verorab®","slug":"verorab","phase":"phase_3","mechanism":"Verorab is a recombinant rabies vaccine.","indications":["Pre-exposure prophylaxis and post-exposure prophylaxis against rabies"],"catalyst":""},{"name":"sIPV vaccine /DTaP vaccine","genericName":"sIPV vaccine /DTaP vaccine","slug":"sipv-vaccine-dtap-vaccine","phase":"marketed","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against poliovirus (sIPV component) and diphtheria, tetanus, and pertussis toxins (DTaP component).","indications":["Prevention of poliomyelitis (poliovirus types 1, 2, and 3)","Prevention of diphtheria","Prevention of tetanus","Prevention of pertussis (whooping cough)"],"catalyst":""},{"name":"sIPV-bOPV-bOPV vaccination schedule","genericName":"sIPV-bOPV-bOPV vaccination schedule","slug":"sipv-bopv-bopv-vaccination-schedule","phase":"phase_3","mechanism":"The sIPV-bOPV-bOPV vaccine stimulates the body's immune system to produce antibodies against poliovirus and rotavirus.","indications":["Prevention of poliomyelitis and rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"sIPV-sIPV-bOPV vaccination schedule","genericName":"sIPV-sIPV-bOPV vaccination schedule","slug":"sipv-sipv-bopv-vaccination-schedule","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"seasonal split influenza vaccine","genericName":"seasonal split influenza vaccine","slug":"seasonal-split-influenza-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"single-person sIPV control vaccine","genericName":"single-person sIPV control vaccine","slug":"single-person-sipv-control-vaccine","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose","genericName":"split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose","slug":"split-virion-adjuvanted-h1n1-vaccine-of-7-5-g-per-dose","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNUHd0Z0ZtWHFtUGphdXBtYTVBWjZUc0lxZXdWRjkzMHRYUldkdk92N1J3NHJ3M0xFWDlPSkxvaER3YkxHRENES2ozR3hOOFJmLVBqTlRTX2laWExkamYxMXdfU2g4M3NWRUQ4V0UyRFhmaUZSVlU5R2N4c0tDRHk3OW9hbGxiLXhvUy1ySm5YSHZKeTJDRXc?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Analysis of Key Market Segments Driving the Inactivated Influenza Vaccine Market - openPR.com","headline":"Analysis of Key Market Segments Driving the Inactivated Influenza Vaccine Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gJBVV95cUxPcHNCN0xmZWgwVk5qY0s2NjNUa2l6bXJ3bWh2Y3JiYjRiVnB3SjZFZ19kajVsOVJrUWZJaUlLaUJZdi16MFpiR3U0R2hyQmgxRTRBVmg4Y3dPakNOWjNoOTJXYWJ0MlpXelA5WTFaTWRrZFFSeU9uSDFYbTR5VXNiT2RfdWxXSjJvd2dBVF82cTJvRi0tTm1Cd2JFUU9FSWFYTjVYTHF6R0ZiUkZLaFIyN2tPNW1ER2pWSU92ZW40cjBqcl8ybll1NjBySVdFZ19zMmVDN2dBYlhJMGNiazZFR19adXVIcWhBdVR2dnpuUVQ0Vkg1eUdzQ0RqZnFidDNFaEVGSnB1ajV6dV9Wc2FXRXlmbkpIWnFaS3BHUk9WMHF6VjRiQkpkelFpeW5sd2NJaFY0TlNVZUwzQ3RxbTl4Xzh4eTdqMkJ1OTZqczVZejdST1N2STJwRlZkTzdoTFY1ZC1ZRkZn?oc=5","date":"2026-01-15","type":"deal","source":"Business Wire","summary":"Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities - Bu","headline":"Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQT24zRjFHSjdKUEdJUGV1QURyd2FrN1FTNmh1V0NSTmEwd2lvQWoydVhsZWJIdW1paXROQ3l2TGF1eUJUWXFSOG81NjVZLVJyYTZuQ2lkcWRBSG9ZZWpvNkxrX3ZNWk1vQko5MGxwa3NtcUp3aU9selVwTGdiZGdRX21KX3ZvVHpEeUVNSVVGSVNPb0xSQ3c?oc=5","date":"2025-12-04","type":"pipeline","source":"Frontiers","summary":"A critical review of Chinese vaccine enterprises in the global aid market: evolution, drivers, and structural constraints - Frontiers","headline":"A critical review of Chinese vaccine enterprises in the global aid market: evolution, drivers, and structural constraint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPOUFpajMwU0ctbzJlNDdHbWRReFNpaXdWRW42ZF9DbHhSUkJwN2Y0SFdOdkV4a0s3LVdmWE53bDRfNmQwY204WDEyN29ETDc4QXFiLUZKNkFYQkdDZ1NoU0tSS19ia19lWXVKTUVtMTN4UExnT2lUWk84bjBhdlhDZ1N4aV9jc0w5dmVZNVFwX1ktSDZ6M3RING4xOXFxM2xJNzBqbzdfYlBRZw?oc=5","date":"2024-10-23","type":"pipeline","source":"BioSpace","summary":"Influenza Vaccine Market Size to Surpass USD 18.02 Billion by 2034 - BioSpace","headline":"Influenza Vaccine Market Size to Surpass USD 18.02 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5GS0xxTnI0WkRRWE44T3VNRkV4MVJSS1dRekg5eW8zTzh6QUZhRTRvd05wODUwVTdEZmdEWVo0YUF0ZEI1U1BlSGNuTFhSajlQU2szNmFlN0pVc3ZOcHVKRUd2Mm9vQ1hOaHZMdHBTblpUX2hiSThUa2tn?oc=5","date":"2022-10-17","type":"pipeline","source":"Fierce Pharma","summary":"The top 10 vaccine companies worldwide - Fierce Pharma","headline":"The top 10 vaccine companies worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPRFZTRFdidnVMM1VZOVBvSWIyZUxUdkpLMURfU2NYR2hwQk85Z252dzQ2MEZkMERQTmhYWTFQYU5iSGV3UmRfTFAtNHRWUU9pNkV4bUk5dC1NblhoSGJVLVRvUzBER0Zsa2RrU1piTWxMMW55QzEzTXR4eW5tb2JsQ08wOA?oc=5","date":"2022-10-05","type":"pipeline","source":"Yahoo Finance","summary":"Global COVID-19 Vaccines Market to Reach $60.7 Billion by 2025 - Yahoo Finance","headline":"Global COVID-19 Vaccines Market to Reach $60.7 Billion by 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbnFfbDU2Vlc0ZW9BcnItOVEta2p2eVBmM3FaaFFERG5CS0tRd2JBd2ZtWXNOd0lXMEZYNG55LS1SaF82T3ltWDFnV2JVQmQzODJjT0RHSGdDOS1LcGJzemZzV2I2cjI1NnVEV0FFSFBKQXhVT05xZlhQQmxWMGNzTjYyOUtnUHczRGdCaTlCQjdjZ3FpbTZyaXZDdktWeWVKc09feVNtbVc5bEVGS09PR29ZSk52Z0t3UkhvbHFDZ2UtWHh3YklxYk45RUo3c1UtOUVZX0FILVozU1MzZTFfREZaYmo1dw?oc=5","date":"2022-08-31","type":"pipeline","source":"PR Newswire","summary":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - PR Newswire","headline":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBZeGNIVXlleEF6cHhlazlJb2J0SnNXVm1KQy10M2lIU2RsX1BoTEFsT0JsZEEzdl8zbU8tbm9EOVZTSWR4c0o0emt0WVBKQk5lejNKTGZ3ZzRFcHNNQkt2Q0hCOXpLQTg?oc=5","date":"2022-02-14","type":"pipeline","source":"Amnesty International","summary":"Money Calls the Shots - Amnesty International","headline":"Money Calls the Shots","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQakptWUdrWjNCeWNpSnBXQ0syakdYaHotbmVXYnRYU3YtTjhZYWJlWVdJWmw5b0JENWhMTk9POExRb0JhR2hnNGVKYkNUTEZfQkRnWlBQZ2FJNDJiTGdIV0NDTW5oa2M1aGQyY1dnYVlVM0xEYktYUWlscHFtOXIza01lcHhndTE5MkN0aFllbjQyTjFLVGJZUTY3V0ZHX3FsS3V2Q1RoVEFpOF9WSGstNEtnTDI0MWZtQUdHUjVfb2NGX1QzaldpRExfV2NQM3N2?oc=5","date":"2021-04-26","type":"regulatory","source":"Reuters","summary":"Egypt approves China's Sinovac coronavirus vaccine for emergency use - Reuters","headline":"Egypt approves China's Sinovac coronavirus vaccine for emergency use","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQZmkzSWo0dDJaVDQzMVdSdDFqZ1lPLXFXNi1lZmFjeEpQbGdwbm90ZzR3M2xPSzItRVZqeFFFakRrc0QzTFFQMndPYUlFaVBhVVNaUFRnNlE4Ujh3SVNKdElUNFhrTzhOdkFfa3RyZmdLdXpUcENJNjVVZkFrRk5DaWFXYlh2YWFOVVR5eUV1ZDBzeUZPLXhyb1RuempKNFk4czdGOTR4NFR6V2pjRl9aUWhMUlJCaVh5cUpreGt2M3U?oc=5","date":"2021-04-26","type":"pipeline","source":"Barron's","summary":"Here’s a Key Player in Covid Vaccines Whose Shares You Can’t Trade—Yet - Barron's","headline":"Here’s a Key Player in Covid Vaccines Whose Shares You Can’t Trade—Yet - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQWjFvZjhHQUVjbDd6Y1NZV2RBZGlrOGl3cHhUQWp4NU9IN0ljbmNSMkhHcVlQWWljNGUxczU2U09ZRDlHU01DcXVwTDhDbUNJa0ItNEdxVHJHaWROb082VlluWjU4MTZvNmNIN19PNk0yb2twN3IzbnZMUG9MaHdUWGRKM2ZTVGswLWdTRWNKNHlxUjY4bDlGX3FTdjBMNTFya1lOeGQ2a3BSX2VLNFE?oc=5","date":"2020-06-16","type":"pipeline","source":"Asian Scientist Magazine","summary":"Sinovac’s CoronaVac Shows Positive Early Results - Asian Scientist Magazine","headline":"Sinovac’s CoronaVac Shows Positive Early Results","sentiment":"neutral"}],"patents":[],"drugCount":61,"phaseCounts":{"marketed":39,"phase_3":15,"phase_2":2,"phase_1":5},"enrichmentLevel":2,"visitCount":11,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}